Ron Martell Jasper Therapeutics, Inc. (JSPR) insider trading activity

JSPR Quotes by TradingView

Ron Martell is President, CEO and Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 331,188 shares of JSPR, which is worth approximately $8.6 Million. The most recent transaction as insider was on Oct 12, 2023, when has been sold 87,531 shares (Voting Common Stock) at a price of $0.85 per share, resulting in proceeds of $74,401. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 331K
0% 3M change
20.9% 12M change
Total Value Held $8.6 Million

RON MARTELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2023
SELL
Payment of exercise price or tax liability
$74,401 $0.85 p/Share
87,531 Reduced 20.9%
331,188 Voting Common Stock
Apr 12 2023
SELL
Payment of exercise price or tax liability
$127,795 $1.46 p/Share
87,531 Reduced 17.29%
418,719 Voting Common Stock
Oct 12 2022
BUY
Grant, award, or other acquisition
-
506,250 Added 50.0%
506,250 Voting Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Executive Chairman
RM

Ron Martell

President, CEO and Director
South San Francisco, CA

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JSPR